286 related articles for article (PubMed ID: 25402957)
1. Epstein-Barr virus latent membrane protein 2A suppresses the expression of HER2 via a pathway involving TWIST and YB-1 in Epstein-Barr virus-associated gastric carcinomas.
Zhang YW; Zhao XX; Tan C; Zhang ZG; Jiang Y; Chen JN; Wei HB; Xue L; Li HG; Du H; Shao CK
Oncotarget; 2015 Jan; 6(1):207-20. PubMed ID: 25402957
[TBL] [Abstract][Full Text] [Related]
2. Establishment and characterization of gastric carcinoma cell clones expressing LMP2A of Epstein-Barr virus.
Seo JS; Jun SM; Kwon SW; Oh IH; Kim TG; Lee SK
Int J Mol Med; 2010 Jan; 25(1):11-6. PubMed ID: 19956896
[TBL] [Abstract][Full Text] [Related]
3. Sequence variations of latent membrane protein 2A in Epstein-Barr virus-associated gastric carcinomas from Guangzhou, southern China.
Han J; Chen JN; Zhang ZG; Li HG; Ding YG; Du H; Shao CK
PLoS One; 2012; 7(3):e34276. PubMed ID: 22470549
[TBL] [Abstract][Full Text] [Related]
4. CXCR4 induces cell autophagy and maintains EBV latent infection in EBVaGC.
Wang W; Zhang Y; Liu W; Zhang X; Xiao H; Zhao M; Luo B
Theranostics; 2020; 10(25):11549-11561. PubMed ID: 33052232
[No Abstract] [Full Text] [Related]
5. Correlation of Epstein-Barr virus and its encoded proteins with Helicobacter pylori and expression of c-met and c-myc in gastric carcinoma.
Luo B; Wang Y; Wang XF; Gao Y; Huang BH; Zhao P
World J Gastroenterol; 2006 Mar; 12(12):1842-8. PubMed ID: 16609989
[TBL] [Abstract][Full Text] [Related]
6. Clinical and pathological characterization of Epstein-Barr virus-associated gastric carcinomas in Portugal.
Ribeiro J; Oliveira A; Malta M; Oliveira C; Silva F; Galaghar A; Afonso LP; Neves MC; Medeiros R; Pimentel-Nunes P; Sousa H
World J Gastroenterol; 2017 Oct; 23(40):7292-7302. PubMed ID: 29142476
[TBL] [Abstract][Full Text] [Related]
7. Differential expression of HER2 and downstream proteins in prediction of advanced tumor phenotypes and overall survival of patients with Epstein-Barr virus-positive vs. negative gastric cancers.
Zhang YW; He D; Tan C; Dong M; Zhou L; Shao CK
Pathol Res Pract; 2019 Nov; 215(11):152675. PubMed ID: 31594682
[TBL] [Abstract][Full Text] [Related]
8. EBV down-regulates COX-2 expression via TRAF2 and ERK signal pathway in EBV-associated gastric cancer.
Qi YF; Liu M; Zhang Y; Liu W; Xiao H; Luo B
Virus Res; 2019 Oct; 272():197735. PubMed ID: 31473273
[TBL] [Abstract][Full Text] [Related]
9. Epstein-Barr virus genome polymorphisms of Epstein-Barr virus-associated gastric carcinoma in gastric remnant carcinoma in Guangzhou, southern China, an endemic area of nasopharyngeal carcinoma.
Chen JN; Jiang Y; Li HG; Ding YG; Fan XJ; Xiao L; Han J; Du H; Shao CK
Virus Res; 2011 Sep; 160(1-2):191-9. PubMed ID: 21723347
[TBL] [Abstract][Full Text] [Related]
10. P53 deregulation in Epstein-Barr virus-associated gastric cancer.
Ribeiro J; Malta M; Galaghar A; Silva F; Afonso LP; Medeiros R; Sousa H
Cancer Lett; 2017 Sep; 404():37-43. PubMed ID: 28729047
[TBL] [Abstract][Full Text] [Related]
11. Deletion of Epstein-Barr virus latent membrane protein 1 gene in Japanese and Brazilian gastric carcinomas, metastatic lesions, and reactive lymphocytes.
Hayashi K; Chen WG; Chen YY; Murakami I; Chen HL; Ohara N; Nose S; Hamaya K; Matsui S; Bacchi MM; Bacchi CE; Chang KL; Weiss LM
Am J Pathol; 1998 Jan; 152(1):191-8. PubMed ID: 9422536
[TBL] [Abstract][Full Text] [Related]
12. LMP2A induces DNA methylation and expression repression of AQP3 in EBV-associated gastric carcinoma.
Wang J; Liu W; Zhang X; Zhang Y; Xiao H; Luo B
Virology; 2019 Aug; 534():87-95. PubMed ID: 31220652
[TBL] [Abstract][Full Text] [Related]
13. Clinical significance of spasmolytic polypeptide-expressing metaplasia and intestinal metaplasia in Epstein-Barr virus-associated and Epstein-Barr virus-negative gastric cancer.
Zhang Y; Chen JN; Dong M; Zhang ZG; Zhang YW; Wu JY; Du H; Li HG; Huang Y; Shao CK
Hum Pathol; 2017 May; 63():128-138. PubMed ID: 28300576
[TBL] [Abstract][Full Text] [Related]
14. Sequence variations of Epstein-Barr virus LMP2A gene in gastric carcinoma in Japan.
Tanaka M; Kawaguchi Y; Yokofujita J; Takagi M; Eishi Y; Hirai K
Virus Genes; 1999; 19(2):103-11. PubMed ID: 10541014
[TBL] [Abstract][Full Text] [Related]
15. [Expression of Epstein-Barr virus genes in EBV-associated gastric carcinoma].
Wang Y; Luo B; Zhao P; Huang BH
Ai Zheng; 2004 Jul; 23(7):782-7. PubMed ID: 15248912
[TBL] [Abstract][Full Text] [Related]
16. LMP2A suppresses the role of AHR pathway through ERK signal pathway in EBV-associated gastric cancer.
Jiang Y; Xiao H; Sun L; Zhang Y; Liu S; Luo B
Virus Res; 2021 May; 297():198399. PubMed ID: 33753181
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathological characteristics and prognosis of Epstein-Barr virus-associated gastric cancer.
Li LL; Yu AY; Zhu M; Ma LY; Cao MH; Liu WL; Qin XB; Gao C; Han ZX; Wang HM
Arch Virol; 2024 May; 169(5):114. PubMed ID: 38700535
[TBL] [Abstract][Full Text] [Related]
18. Survival advantage of EBV-associated gastric carcinoma: survivin up-regulation by viral latent membrane protein 2A.
Hino R; Uozaki H; Inoue Y; Shintani Y; Ushiku T; Sakatani T; Takada K; Fukayama M
Cancer Res; 2008 Mar; 68(5):1427-35. PubMed ID: 18316606
[TBL] [Abstract][Full Text] [Related]
19. [Clinicopathologic features and protein expression study of Epstein-Barr virus-associated gastric carcinoma in Guangzhou].
Han J; He D; Feng ZY; Ding YG; Shao CK
Zhonghua Bing Li Xue Za Zhi; 2010 Dec; 39(12):798-803. PubMed ID: 21215093
[TBL] [Abstract][Full Text] [Related]
20. Glypican-4 gene polymorphism (rs1048369) and susceptibility to Epstein-Barr virus-associated and -negative gastric carcinoma.
Zhao D; Liu S; Sun L; Zhao Z; Liu S; Kuang X; Shu J; Luo B
Virus Res; 2016 Jul; 220():52-6. PubMed ID: 27071854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
